[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
July 21, 1962

Clinical Differentiation Between Thyroid Cancer and Benign Goiter: An Evaluation

Author Affiliations

From the Divisions of Medicine and Surgery, Roswell Park Memorial Institute, New York State Department of Health.

JAMA. 1962;181(3):179-185. doi:10.1001/jama.1962.03050290001001

The ability of skilled physicians to estimate cancer risk in nontoxic goiter was determined by reviewing 235 evaluations of patients referred as thyroid cancer suspects and comparing the diagnostic impressions with the subsequent clinical and histological findings. Of 202 patients classified as "benign" on clinical evaluation, 2% proved to have thyroid cancer. In contrast, 28% of those classified as "suspected of cancer" and 53% of those classified as "probably cancer" did indeed have malignant goiters. Furthermore, although only 63 patients with "benign" goiters were subjected to early thyroidectomy, these included all 4 with thyroid cancer so far identified in this group. These figures indicate that patients with goiter can be divided quite successfully into low and high cancer-risk groups and that preoperative selection is justified.

Sokal, J. E.:  Problem of Malignancy in Nodular Goiter; Recapitulation and Challenge ,  JAMA 170:405-412 ( (May 23) ) 1959.Crossref
Sokal, J. E.:  Long-Term Follow-Up of Nontoxic Nodular Goiter ,  Arch Intern Med 99:60-69 ( (Jan.) ) 1957.Crossref
Sokal, J. E.:  Incidence of Thyroid Cancer and Problem of Malignancy in Nodular Goiter , in  Clinical Endocrinology I , Edwin B. Astwood, ed., New York: Grune and Stratton, 1960, pp. 168-178.
Shimaoka, K.; Sokal, J. E.; and Pickren, J. W.: Metastatic Neoplasms in Thyroid Gland: Pathological and Clinical Findings, to be published.
Marchetta, F. C. et al.:  Carcinoma of Thyroid Gland. Clinical and Histologic Features Which Influence Results of Therapy ,  New York J Med 57:3305-3314 ( (Oct. 15) ) 1957.
Crile, G., Jr.; Suhrer, J. G.; and Hazard, J. B.:  Results of Conservative Operations for Malignant Tumors of Thyroid ,  J Clin Endocr 15:1422-1431 ( (Nov.) ) 1955.Crossref
Miller, J. M.:  Carcinoma and Thyroid Nodules. Problem in Endemic Goiter Area ,  New Engl J Med 252:247-251 ( (Feb. 17) ) 1955.Crossref
Eberbach, C. W.:  Surgical Indications in Nontoxic Nodular Goiter; Controversial Problem ,  Wisconsin Med J 58:209-214 ( (April) ) 1959.
Majarakis, J. D.; Slaughter, D. P.; and Cole, W. H.:  Carcinoma of Thyroid Gland ,  J Clin Endocr 13:1530-1541 ( (Dec.) ) 1953.Crossref
Cerise, E. J.; Randall, S.; and Ochsner, A.:  Carcinoma of Thyroid and Nontoxic Nodular Goiter ,  Surgery 31:552-561, 1952.
Lahey, F. H., in discussion of Cole, W. H.; Slaughter, D. P.; and Ressiter, L. J.:  Potential Dangers of Nontoxic Nodular Goiter ,  JAMA 127:883-888 ( (April 7) ) 1945.Crossref
Trevor, W.:  Should Thyroid Nodule Be Removed? ,  Curr Med Digest 21:86-89 ( (Nov.) ) 1954.
Hare, H. F., and Salzman, F. A.:  Cancer of Thyroid: Ten to Twenty Year Follow-Up ,  Amer J Roentgenol 63:881-887 ( (June) ) 1950.
Crile, G., Jr.:  Factors Influencing Prevention and Cure of Cancer of Thyroid ,  Surg Gynec Obstet 91:210-214 ( (Aug.) ) 1950.
Beahrs, O. H., and Judd, E. S., Jr.:  Malignant Lesions of Thyroid Gland ,  Surg Clin N Amer 31:1169-1177 ( (Aug.) ) 1951.
Cohen, M., and Moore, G. E.:  Malignant Lesions of Thyroid ,  Surgery 35:62-76 ( (Jan.) ) 1954.
Macksood, W.; Rapport, R. L.; and Hodges, F.:  Increasing Incidence of Hashimoto's Disease ,  Arch Surg 83:384-387 ( (Sept.) ) 1961.Crossref
Greer, M. A., and Astwood, E. B.:  Treatment of Simple Goiter with Thyroid ,  J Clin Endocr 13:1312-1331 ( (Nov.) ) 1953.Crossref
Badillo, J.; et al.: Response of Nontoxic Nodular Goiter to Triiodothyronine Therapy: A Double-Blind Study, unpublished data.